6505--Glipizide Tablets
Key Dates
Due Date
-
Posted Date
-
Agency & Value
Agency
NAC PHARMACEUTICALS (36E797)
Contract Value
Not provided
Codes & Classification
Solicitation Number
36E79726R0031_1
NAICS
325412 - Pharmaceutical Preparation Manufacturing
Classification Code
6505
Additional Details
Documents4
The Department of Veterans Affairs (VA) National Acquisition Center (NAC) has announced a forthcoming procurement opportunity for Glipizide Tablets, as detailed in presolicitation notice 36E79726R0031_1. This initiative is designed to secure a reliable, uninterrupted supply of Glipizide Tablets for a broad spectrum of federal healthcare entities, including the VA (encompassing Consolidated Mail Order Pharmacies and State Veterans Homes under Option 2), the Department of Defense (DoD), the Bureau of Prisons (BOP), the Indian Health Service (IHS), and the Federal Health Care Center (FHCC).
The procurement will be conducted as an unrestricted competition, with the intent to award a single contract to a responsible offeror capable of meeting the comprehensive supply requirements. The contract will span a base period of one year, with the possibility of four additional one-year option periods, all pre-priced. Distribution of the contracted items will occur through the VA’s and DoD’s respective Pharmaceutical Prime Vendor Programs, ensuring efficient and widespread access to the medication across the participating agencies.
Key requirements for this procurement include the provision of Glipizide Tablets in various strengths and packaging configurations. Specifically, the solicitation will cover both 5mg and 10mg tablet strengths, with unit-of-use packaging in bottle sizes of 90, 180, and 360 tablets, as well as bulk packaging options of 500 or 1,000 tablets per bottle. The estimated annual usage is substantial, with requirements such as 60,691 bottles of 5mg tablets (90-count) and 88,612 bottles of 10mg tablets (180-count), among others. Offerors must ensure that their products are supplied under a unique National Drug Code (NDC) specific to their label, and that no relabeling over another manufacturer’s label occurs. The successful contractor’s label will be the only one on the product, though VA labels must be able to securely adhere over the contractor’s label.
Packaging specifications are detailed and must be strictly adhered to. Bottles must be of a minimum 120cc volume, with a cylindrical body and a minimum circumference of 5.75 inches. The safety cap must not exceed the bottle’s diameter and should be convertible to a non-safety cap if required. The label area must accommodate a 5.25 x 2 inch label, with an additional 0.5 inch to ensure barcode visibility and clear display of expiration date and lot number.
The solicitation will be issued electronically in accordance with FAR Part 12 (Commercial Items) on or about July 27, 2026, with a tentative closing date of August 10, 2026. All documents, amendments, and updates will be available exclusively through SAM.gov; no paper copies will be provided. Interested offerors are encouraged to monitor the SAM.gov portal for any changes or additional information related to this opportunity.
The procurement is classified under NAICS code 325412 (Pharmaceutical Preparation Manufacturing), with the Product Service Code (PSC) 6505. The contracting entity is NAC Pharmaceuticals (36E797), a federal office within the Department of Veterans Affairs. The primary point of contact for this solicitation is Deb Fassl, who can be reached at [email protected] or by phone at 708-786-5894.
This opportunity represents a significant and stable requirement for pharmaceutical manufacturers and distributors with the capacity to meet stringent federal standards for drug labeling, packaging, and supply continuity. Contractors with experience in large-scale pharmaceutical fulfillment and compliance with federal healthcare procurement protocols are well-positioned to consider this opportunity.